Skip to main content
Article thumbnail
Location of Repository

Small-volume resuscitation with hyperoncotic albumin: a systematic review of randomized clinical trials

By Matthias Jacob, Daniel Chappell, Peter Conzen, Mahlon M Wilkes, Bernhard F Becker and Markus Rehm
Topics: Research
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles


    1. (2005). A randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis. Hepatology
    2. (1980). Acute effects of albumin infusion on blood volume and renal function in premature infants with respiratory distress syndrome.
    3. (1984). AG: Intracranial and systemic effects of osmotic and oncotic therapy in experimental cerebral edema.
    4. (2002). Albumin and hypovolaemia: is the Cochrane evidence to be trusted? Lancet
    5. (1999). Albumin or hetastarch improves neurological outcome and decreases volume of brain tissue necrosis but not brain edema following closed-head trauma in rats.
    6. Albumin therapy for patients with increased intracranial pressure: oncotic therapy. No Shinkei Geka 1983, 11:947-954.Available online Page 13 of 13 (page number not for citation purposes)
    7. (1981). Albumin treatment following major surgery. I. Effects on plasma oncotic pressure, renal function and peripheral oedema. Acta Anaesthesiol Scand
    8. (1995). Altman DG: Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA
    9. (1992). Bezemer PD: Custom-tailored hemodilution with albumin and crystalloids in acute ischemic stroke. Stroke
    10. (1997). Bias in metaanalysis detected by a simple, graphical test. BMJ
    11. (1980). blood volume, and oxygen transport responses to albumin and hydroxyethyl starch infusions in critically ill postoperative patients. Crit Care Med
    12. (1997). C: Effects of preoperative intentional hemodilution on the extravasation rate of albumin and fluid. Crit Care Med
    13. (1942). CA: The use of human albumin in military medicine. Part I. The theoretical and experimental basis for its use.
    14. (1992). Calandrino FS, Schuster DP: Improved outcome based on fluid management in critically ill patients requiring pulmonary artery catheterization. Am Rev Respir Dis
    15. (1977). Cardiac output and pulmonary wedge pressure. Use for evaluation of fluid replacement in trauma patients. Arch Surg
    16. (2005). Christ F: Effect of hypertonic saline dextran on acidbase balance in patients undergoing surgery of abdominal aortic aneurysm. Crit Care Med
    17. (1991). Concentrated albumin infusion as an aid to postoperative recovery after pelvic exenteration. Gynecol Oncol
    18. (2006). De R o b e r t i s E , P i a z z a O , T u f a n o R : The effects of hydroxyethyl starch solution in critically ill patients. Minerva Anestesiol
    19. (1948). DH: Pure serum albumin compared with citrated plasma in the therapy of chronic hypoalbuminemia. Ann Surg
    20. (2001). Dodek PM: Distribution of normal saline and 5% albumin infusions in cardiac surgical patients. Crit Care Med
    21. (1999). Dodek PM: Distribution of normal saline and 5% albumin infusions in septic patients. Crit Care Med
    22. (2001). Does albumin preinfusion potentiate diuretic action of furosemide in patients with nephrotic syndrome?
    23. (1980). DW: Impaired pulmonary function after albumin resuscitation from shock.
    24. (2001). Ece A: Beneficial effect of human albumin on neonatal cerebral edema.
    25. (1990). Effect of intraoperative fluid administration and colloid osmotic pressure on the formation of intestinal edema during gastrointestinal surgery.
    26. (1999). Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.
    27. (2002). Effects of intravenous human albumin and furosemide on EEG recordings in patients with intracerebral hemorrhage. Clin Neurophysiol
    28. (2001). Finsterer U: Changes in blood volume and hematocrit during acute preoperative volume loading with 5% albumin or 6% hetastarch solutions in patients before radical hysterectomy. Anesthesiology
    29. (2000). Finsterer U: Changes in intravascular volume during acute normovolemic hemodilution and intraoperative retransfusion in patients with radical hysterectomy. Anesthesiology
    30. (1995). Finsterer U: Isovolemic hemodilution alters the ratio of whole-body to large-vessel hematocrit (F-cell ratio). A prospective, randomized study comparing the volume effects of hydroxyethyl starch 200,000/0.62 and albumin. Infusionsther Transfusionsmed
    31. (2001). Finsterer U: Veränderungen des Blutvolumens während akuter normovolämer Hämodilution mit 5% Albumin und 6% Hydroxyethylstärke und intraoperativer Retransfusion. Anaesthesist
    32. (1999). Franek E, Ritz E: Coadministration of albumin and furosemide in patients with the nephrotic syndrome. Kidney Int
    33. (1988). Gamsu HR: Immediate effects of albumin infusion in ill premature neonates. Arch Dis Child
    34. (1993). Gamsu HR: Randomised controlled trial of albumin infusion in ill preterm infants.
    35. (1998). Ginsberg MD: The effect of high-dose albumin therapy on local cerebral perfusion after transient focal cerebral ischemia in rats. Brain Res
    36. (2000). Grände PO: Effects on capillary fluid permeability and fluid exchange of albumin, dextran, gelatin, and hydroxyethyl starch in cat skeletal muscle. Crit Care Med
    37. (1998). Group Albumin Reviewers: Human albumin administration in critically ill patients: systematic review of randomised controlled trials. BMJ
    38. (1997). Hedenstierna G: Central and regional hemodynamics during acute hypovolemia and volume substitution in volunteers. Crit Care Med
    39. (1995). Hempelmann G: Does the type of volume therapy influence endothelialrelated coagulation in the critically ill?
    40. (1996). Hempelmann G: Influence of different volume therapy regimens on regulators of the circulation in the critically ill.
    41. (1996). Hempelmann G: The effects of albumin versus hydroxyethyl starch solution on cardiorespiratory and circulatory variables in critically ill patients. Anesth Analg
    42. (1993). Hempelmann G: Volume replacement with hydroxyethyl starch solution in children.
    43. (1998). Hempelmann G: Volume therapy in the critically ill: is there a difference? Intensive Care Med
    44. (1986). Hempelmann G: Volumenersatz mit einem neuen HydroxyäthylstärkePräparat (3% HÄS 200/0,5) in der Herzchirurgie. Infusionsther Klin Ernahr
    45. (1996). Hempelmann GG: Influence of different volume therapies and pentoxifylline infusion on circulating soluble adhesion molecules in critically ill patients. Crit Care Med
    46. (2003). How meta-analysis increases statistical power. Psychol Methods
    47. (1996). Influence of different volume therapies on platelet function in the critically ill. Intensive Care Med
    48. (2004). Investigators: A comparison of albumin and saline for fluid resuscitation in the intensive care unit.
    49. (2001). L: Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet
    50. (1999). Laffi G: Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial.
    51. (1999). Lagonidis D: Effectiveness of albumin versus normal saline as a test of volume responsiveness in post-cardiac surgery patients. J Crit Care
    52. (2000). Leunissen KM: Effect of intravenous fluids on blood pressure course during hemodialysis in hypotensive-prone patients.
    53. (1999). Leunissen KM: Effect of intravenous saline, albumin, or hydroxyethylstarch on blood volume during combined ultrafiltration and hemodialysis.
    54. (1976). Liljedahl SO: Plasma volume expansion after infusion of 5%, 20% and 25% albumin solutions in patients. Resuscitation
    55. (1948). LK: Plasma protein studies on normal newborn and premature infants. I. Plasma protein values for normal full term and normal premature infants; II. Use of concentrated normal human serum albumin in treatment of premature infants.
    56. (1991). Low molecular weight hydroxyethyl starch 6% compared to albumin 4% during intentional hemodilution. Intensive Care Med
    57. (2000). Manthous CA: Negative fluid balance predicts survival in patients with septic shock: a retrospective pilot study. Chest
    58. (1999). MD: Posttreatment with high-dose albumin reduces histopathological damage and improves neurological deficit following fluid percussion brain injury in rats.
    59. (1999). MD: Protein extravasation and cellular uptake after highdose human-albumin treatment of transient focal cerebral ischemia in rats. Brain Res
    60. (2006). MD: The ALIAS (ALbumin In Acute Stroke) Phase III randomized multicentre clinical trial: design and progress report. Biochem Soc Trans
    61. (1987). Meretoja OA: Effects of concentrated albumin treatment after aortocoronary bypass surgery. Crit Care Med
    62. (2001). Meßmer K: Small volume – large benefit? Anaesthesist
    63. (2003). MM: Albumin administration – what is the evidence of clinical benefit? A systematic review of randomized controlled trials.
    64. (2003). MM: Hypoalbuminemia in acute illness: is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials. Ann Surg
    65. (2004). MM: Morbidity in hospitalized patients receiving human albumin: a meta-analysis of randomized, controlled trials. Crit Care Med
    66. (2001). Navickis RJ: Patient survival after human albumin administration: a meta-analysis of randomized, controlled trials. Ann Intern Med
    67. (2004). NC: Changes in serum albumin concentration and volume expanding effects following a bolus of albumin 20% in septic patients.
    68. On the absorption of fluids from connective tissue spaces.
    69. (2000). Pathophysiology of septic encephalopathy: a review. Crit Care Med
    70. (2008). Reinhart K: Intensive insulin therapy and pentastarch resuscitation in severe sepsis. The German Competence Network Sepsis (SepNet).
    71. (2005). RG: Volume expansion and plasma protein clearance during intravenous infusion of 5% albumin and autologous plasma. Clin Sci (Lond)
    72. (1997). RJ: Organ damage is preceded by changes in protein extravasation in an experimental model of multiple organ dysfunction syndrome. Shock
    73. (2002). SA: Global cerebral edema after subarachnoid hemorrhage: frequency, predictors, and impact on outcome. Stroke
    74. (2002). SA: Predictors of cognitive dysfunction after subarachnoid hemorrhage. Stroke
    75. (1987). Sastrosubroto H: Therapeutic use of albumin in nephrotic syndrome. Paediatr Indones
    76. (1984). Sawka MN: Albumin-induced plasma volume expansion: diurnal and temperature effects.
    77. (2000). Sun L: Human neutrophil activation and increased adhesion by various resuscitation fluids. Crit Care Med
    78. (2006). Tamariz D: The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke – I: Physiological responses and safety results. Stroke
    79. (2000). The appropriate role of colloids in managing fluid imbalance: a critical review of recent meta-analytic findings. Crit Care
    80. (1989). The cardiovascular and oncotic effects of albumin infusion in premature infants. Early Hum Dev
    81. (1994). Tominaga B: High colloid oncotic therapy for brain edema with cerebral hemorrhage. Acta Neurochir Suppl
    82. (1994). Tominaga B: High colloid oncotic therapy for contusional brain edema. Acta Neurochir Suppl
    83. (2004). TW: Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury. Crit Care Med
    84. (2001). Vitrinel A: Does albumin and furosemide therapy affect plasma volume in nephrotic children? Pediatr Nephrol
    85. (2005). VM: Is albumin administration in the acutely ill associated withCritical

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.